United States · FDA National Drug Code directory
benazepril hydrochloride and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-221_4b924079-c490-67c8-e063-6394a90aa7d0
- Product NDC
- 72888-221
- Form
- TABLET
- Composition / generic term
- benazepril hydrochloride and hydrochlorothiazide
- Labeler
- Advagen Pharma Ltd
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20241205
- Source listing expiry
- 20271231
Source-listed ingredients
- BENAZEPRIL HYDROCHLORIDE — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (72888-221-01) · 72888-221-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →